查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1608827

脑膜炎疫苗市场：依类型、品牌、血清型、销售管道、地区

Meningitis Vaccines Market, By Type, By Brand, By Serotype, By Sales Channel, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 359 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计2024年脑膜炎疫苗市场规模为37.2亿美元，2031年将达58.1亿美元，2024年至2031年复合年增长率为6.6%。

分析范围 分析详情
基准年 2023年 市场规模（2024年） 37.2亿美元
实际资料 2019-2023 预测期 2024-2031
预测期复合年增长率（2024-2031） 6.60% 预计金额（2031年） 58.1亿美元
图：2024 年按地区分類的脑膜炎疫苗市场占有率（%）
脑膜炎疫苗市场-IMG1

脑膜炎是覆盖大脑和脊髓的保护膜（称为脑膜）的致命发炎。脑膜炎是由多种病原体引起的，包括细菌、病毒、寄生虫和真菌。脑膜炎最常见的原因是病毒和细菌感染。如果不及时使用适当的抗生素治疗，由脑膜炎奈瑟菌、肺炎链球菌和 B 型流感嗜血桿菌引起的细菌感染可能会迅速恶化并致命。虽然及时使用抗生素治疗可以治癒大多数细菌性脑膜炎病例，但感染疾病仍会导致长期残疾，例如 10-15% 的病例可能导致听力丧失、神经发育迟缓、癫痫和截肢。建议接种疫苗以预防脑膜炎奈瑟菌引起的侵袭性脑膜炎双球菌疾病的发生。脑膜炎双球菌结合疫苗的开发可提供直接保护和群体免疫，有效控制疾病在社区内的传播。

市场动态

脑膜炎疫苗的全球市场成长主要是由侵袭性脑膜炎双球菌病菌感染负担的增加和全球大规模免疫计画的实施所推动的。例如，根据世界卫生组织（WHO）2021年发布的资料，脑膜炎每年导致约25万至50万例病例和超过3万人死亡，使其成为公共卫生重点。导致疫情爆发的常见致病血清群的流行病学不断发展、国家监管机构对常规免疫的建议以及组合疫苗的可用性预计将在预测期内增加市场供应量，从而提供强劲的增长机会。然而，製造和开发新疫苗的高成本、疫情期间疫苗缺货以及低收入和中等收入国家缺乏意识等因素可能会阻碍市场成长。涵盖新兴血清型的廉价多效价疫苗的市场开拓以及开发中国家免疫规划的扩大为参与者进入并进一步扩大市场提供了有利可图的机会。

本研究的主要特点

该报告对全球脑膜炎疫苗市场进行了详细分析，并提供了以2023年为基准年的预测期（2024-2031年）的市场规模和年复合成长率（CAGR%）。

它还揭示了各个细分市场的潜在商机，并说明了该市场有吸引力的投资提案矩阵。

它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。

根据公司亮点、产品系列、主要亮点、绩效和策略等参数，包括全球脑膜炎疫苗市场的主要企业概况。

主要企业包括辉瑞、赛诺菲、葛兰素史克、印度血清研究所有限公司、默克公司、沃森生物科技有限公司、伊西普达製药有限公司、华兰生物工程有限公司等。

从这份报告中获得的见解将帮助负责人和公司经营团队就未来的产品发布、产品升级、市场扩张和行销策略做出明智的决策。

全球脑膜炎疫苗市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。

目录

第一章 分析目的与前提

  • 分析目的
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要

第三章市场动态、法规与趋势分析

  • 市场动态
  • 影响分析
  • 主要亮点
  • 监管场景
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 企业合併(M&A) 场景
  • 流行病学

第 4 章 脑膜炎疫苗市场：按类型划分，2019-2031 年（十亿美元）

  • 二价
  • 四价
  • 其他的

第五章 脑膜炎疫苗市场：依品牌划分，2019-2031（十亿美元）

  • 门夸德菲
  • 门贝奥
  • 托门巴
  • 贝克塞洛
  • 其他的

第六章 脑膜炎疫苗市场：依年龄层划分，2019-2031（十亿美元）

  • 婴儿
  • 成人

第 7 章 脑膜炎疫苗市场，依血清型划分，2019-2031 年（十亿美元）

  • A血清型
  • B血清型
  • C血清型
  • 血清型 W-135
  • 其他的

第八章 脑膜炎疫苗市场：依销售管道划分，2019-2031（十亿美元）

  • 私人的
  • 公共

第九章 脑膜炎疫苗市场：按地区划分，2019-2031 年（十亿美元）

  • 北美洲
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第10章竞争格局

  • Pfizer Inc.
  • Sanofi
  • GSK plc.
  • Serum Institute of India Ltd.
  • Merck & co., Inc.
  • Walvax Biotechnology Co., Ltd.
  • Icepta Pharmaceuticals Ltd.
  • Hualan Biological Engineering Inc.

第十一章分析师建议

  • 《命运之轮》
  • 分析师观点
  • Coherent Opportunity Map (COM)

第十二章参考文献与调查方法

  • 参考
  • 分析方法
  • 关于相干市场洞察
简介目录
Product Code: CMI5042

Meningitis vaccines market is estimated to be valued at USD 3.72 Bn in 2024 and is expected to reach USD 5.81 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.6% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: 3.72 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2024 to 2031 CAGR: 6.60% 2031 Value Projection: 5.81 Bn
Figure. Meningitis Vaccines Market Share (%), By Region, 2024
Meningitis Vaccines Market - IMG1

Meningitis is a potentially fatal inflammation of the protective membranes covering the brain and spinal cord known as meninges. It can be caused by various pathogens such as bacteria, viruses, parasites, and fungi. The most common causes of meningitis are viral and bacterial infections. Bacterial infections including those caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae type b can rapidly lead to serious illness and even death if not treated promptly with appropriate antibiotics. While timely treatment with antibiotics can cure most cases of bacterial meningitis, the infection may still lead to long-term disability in 10-15% of cases such as hearing loss, neurodevelopmental delay, and epilepsy or limb amputations. To prevent the occurrence of invasive meningococcal disease caused by N. meningitidis, vaccination is recommended. Meningococcal conjugate vaccines have been created to provide both direct protection and herd immunity, effectively controlling the spread of the disease within communities.

Market Dynamics

Global meningitis vaccines market growth is primarily driven by increasing burden of invasive meningococcal disease and implementation of large-scale immunization programs worldwide. For instance, as per the data published by the World Health Organization (WHO) in 2021, meningitis causes approximately 250,000-500,000 cases annually resulting in over 30,000 deaths, making it a public health priority. Evolving epidemiology of common pathogenic serogroups causing outbreaks, recommendations for routine immunization by national regulatory bodies and availability of vaccine combinations are expected to create robust growth opportunities in the market during the forecast period. However, factors such as high costs associated with the manufacturing and development of novel vaccines, vaccine stockouts during outbreaks, and lack of awareness in low and middle-income countries can hamper the market growth. Development of affordable multivalent vaccines covering emerging serotypes and expansion of immunization programs in developing nations present lucrative opportunities for player engagement and further market expansion.

Key Features of the Study

This report provides in-depth analysis of the global meningitis vaccines market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global meningitis vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Pfizer Inc., Sanofi, GSK plc., Serum Institute of India Ltd., Merck & co., Inc., Walvax Biotechnology Co., Ltd., Icepta Pharmaceuticals Ltd., and Hualan Biological Engineering Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global meningitis vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Market Segmentation

  • Type Insights
    • Bivalent
    • Quadrivalent
    • Others
  • Brand Insights
    • MenQuadfi
    • Menveo
    • Trumenba
    • Bexsero
    • Others
  • Age Group Insights
    • Infants
    • Adults
  • Serotype Insights
    • Serotype A
    • Serotype B
    • Serotype C
    • Serotype W-135
    • Others
  • Sales Channel Insights
    • Private
    • Public
  • Regional Insights
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Pfizer Inc.
    • Sanofi
    • GSK plc.
    • Serum Institute of India Ltd.
    • Merck & co., Inc.
    • Walvax Biotechnology Co., Ltd.
    • Icepta Pharmaceuticals Ltd.
    • Hualan Biological Engineering Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Meningitis Vaccines Market, By Type
    • Meningitis Vaccines Market, By Brand
    • Meningitis Vaccines Market, By Age Group
    • Meningitis Vaccines Market, By Serotype
    • Meningitis Vaccines Market, By Sales Channel
    • Meningitis Vaccines Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Epidemiology

4. Meningitis Vaccines Market, By Type, 2019-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Bivalent
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Quadrivalent
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Meningitis Vaccines Market, By Brand, 2019-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • MenQuadfi
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Menveo
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Trumenba
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Bexsero
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Meningitis Vaccines Market, By Age Group, 2019-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Infants
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Adults
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Meningitis Vaccines Market, By Serotype, 2019-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Serotype A
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Serotype B
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Serotype C
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Serotype W-135
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Meningitis Vaccines Market, By Sales Channel, 2019-2031, (USD Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Private
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Public
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

9. Meningitis Vaccines Market, By Region, 2019 - 2031, (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2024,2027 & 2031, (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2020 - 2031, (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Brand, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Age Group, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Serotype, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Sales Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, Country, 2019 - 2031, (USD Bn)
    • U.S.
    • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Brand, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Age Group, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Serotype, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Sales Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, Country, 2019 - 2031, (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Brand, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Age Group, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Serotype, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Sales Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, Country, 2019 - 2031, (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Brand, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Age Group, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Serotype, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Sales Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, Country, 2019 - 2031, (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Brand, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Age Group, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Serotype, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Sales Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, Country, 2019 - 2031, (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Brand, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Age Group, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Serotype, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, By Sales Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, Country/Region, 2019 - 2031, (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

10. Competitive Landscape

  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sanofi
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GSK plc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Serum Institute of India Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck & co., Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Walvax Biotechnology Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Icepta Pharmaceuticals Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hualan Biological Engineering Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us